Artigo Acesso aberto Produção Nacional

Efeito terapêutico de Ranibizumabe em edema macular e perfusão retiniana associado a raro caso de Eales Central

2016; Conselho Brasileiro de Oftalmologia; Volume: 2; Issue: 1 Linguagem: Inglês

10.17545/e-oftalmo.cbo/2016.75

ISSN

2359-3962

Autores

André Luís Ayres da Fonsêca, Fernanda Maria Silveira Souto, Heitor Panetta, Maurício Abujamra Nascimento, Andréa Mara Simões Torigoe,

Tópico(s)

Vasculitis and related conditions

Resumo

Eales disease is an idiopathic peripheral vasculopathy involving the retina that primarily affects healthy young men. The clinical manifestations consist of three characteristic findings: peripheral retinal vasculitis, capillary nonperfusion, and neovascularization of the retina and the optic disc. Few case studies describe the rare form of central involvement in the disease, known as central Eales disease. In it, the typical findings of Eales disease occur in the posterior pole. Eales disease treatment depends on the clinical stage of the disease. Anti-VEGF therapy has recently been used. This report describes the case of a healthy young man with this rare form of Eales disease and the favorable outcome of intravitreal therapy with ranibizumab used in combination with panretinal photocoagulation. Satisfactory clinical improvement was observed in the eye that underwent intravitreal anti-VEGF treatment with ranibizumab, particularly in terms of the reduction in retinal thickness in the macular region and improvement in visual acuity.

Referência(s)